Serotonin inhibits epileptiform discharge by activation of 5-HT(1A) receptors in CA1 pyramidal neurons

Neuropharmacology

Volumn 36, Issue 11-12, 1997, Pages 1705-1712

  Salgado Commissariat, Delanthi ^a   Alkadhi, Karim A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

8 OH DPAT; Bicuculline; Epilepsy model; Fluoxetine; Hippocampus

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BICUCULLINE; FLUOXETINE; KETANSERIN; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1A RECEPTOR;

ACTION POTENTIAL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; EPILEPTIC DISCHARGE; HIPPOCAMPUS; HYPERPOLARIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BARIUM COMPOUNDS; BICUCULLINE; CHLORIDES; ELECTROPHYSIOLOGY; EPILEPSY; FLUOXETINE; GABA ANTAGONISTS; HIPPOCAMPUS; MAGNESIUM; MALE; MEMBRANE POTENTIALS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031431193     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00134-2     Document Type: Article

References (33)

1. Andrade R. and Chaput Y. (1991) 5-Hydroxytryptamine 4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. Journal of Pharmacology and Experimental Therapeutics 257: 930-937.
2. Andrade R. and Nicoll R. A. (1987) Pharmacologically distinct action of serotonin on single pyramidal neurons of the rat hippocampus recorded in vitro. Journal of Physiology 394: 99-124.
3. Beck S. G., Choi K. C. and List T. J. (1992) Comparison of 5-HT1A-mediated hyper-polarization in CA1 and CA3 hippocampal pyramidal cells. Journal of Pharmacology and Experimental Therapeutics 263: 350-359.
4. Bekkers J. M. and Stevens C. F. (1993) NMDA receptors at excitatory synapses in the hippocampus: test of a theory of magnesium block. Neuroscience Letters 156: 73-77.
5. Blier P. and DeMontigny C. (1990) Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single cell recording studies. Journal of Clinical Psychopharmacology 10 (Suppl. 3): 13S-20S.
6. Bonnycastle D. D., Giarman N. J. and Paasonen M. K. (1957) Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. British Journal of Pharmacology 12: 228-231.
7. Colino A. and Halliwell J. V. (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature 328: 73-77.
8. Dailey J. W., Yan Q. S., Mishra P. K., Burger R. C. and Jobe P. C. (1992b) Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. Journal of Pharmacology and Experimental Therapeutics 260: 533-540.
9. Dailey J. W., Yan Q. S., Adams-Curtis L. E., Ryu J. R., Ko K. H., Mishra P. K. and Jobe P. C. (1995) Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Science 58: 259-266.
10. Darrow E., Strahlendorf J. C. and Strahlendorf H. K. (1991) Extracellular magnesium concentration alters Purkinje cell responsiveness to serotonin and analogues. European Journal of Pharmacology 209: 19-25.
11. De Montigny C. and Blier P. (1992) Electrophysiological evidence for the distinct properties of presynaptic and postsynaptic 5-HT1A receptors: possible clinical relevance. In: Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications (Langer S. Z., Brunello N., Racagni G. and Mendlewicz G.), Journal of the International Academy of Biomedical Drug Research, Vol. 1, pp. 80-88. Karger, Basel, Switzerland.
12. Fletcher A., Bill D. J., Bill S. J., Cliffe I. A., Dover G. M., Forster E. A., Haskins J. T., Jones D., Mansell H. L. and Reilley Y. (1993) WAY 100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. European Journal of Pharmacologv 237: 283-291.
13. Gozlan H., El Mestikawy S., Pichat L., Glowinski J. and Hamon M. (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305: 140-143.
14. Herron C. G., Lester R. A. J., Coan E. J. and Collingridge A. L. (1985) Intracellular demonstration of an N-methyl-D-aspartate receptor mediated component of synaptic transmission in the rat hippocampus. Neuroscience Letters 60: 19-23.
15. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. A. (1994) VII International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Reviews 46: 158-176.
16. Janssen P. A. J. (1983) 5-HT2 receptor blockade to study serotonin-induced pathology. Trends in Pharmacological Sciences 4: 198-206.
17. 2+ and tetramethylammonium on cortical neurons. Journal of Physiology 215: 223-245.
18. Loscher W. and Czuczwar S. J. (1985) Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamine) tetralin in different rodent models of epilepsy. Neuroscience Letters 60: 201-206.
19. Mody I., Lambert J. D. C. and Heinemann U. (1987) Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. Journal of Neurophysiology 57: 869-888.
20. Okuhara D. Y. and Beck S. G. (1994) 5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells. Journal of Neurophysiology 71: 2161-2167.
21. Pazos A. and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-I receptors. Brain Research 346: 205-230.
22. Pasini A., Tortorella A. and Gale K. (1992) Anticonvulsant effect of intranigral fluoxetine. Brain Research 593: 287-290.
23. Pasini A., Tortorella A. and Gale K. (1996) The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Research 724: 84-88.
24. Salgado D. and Alkadhi K. A. (1995) Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Research 669: 176-182.
25. Salgado-Commissariat D. and Alkadhi K. A. (1996) Effects of serotonin on induced epileptiform activity in CA1 pyramidal neurons of genetically epilepsy prone rats. Brain Research 743: 212-216.
26. Schwartzkroin P. A. (1986) Hippocampal slices in experimental and Human epilepsy. In: Advances in Neurology (Degado-Escueta A. V., Ward A. A. Jr, Woodbury D. M. and Porter R. J.), Vol.44, pp. 991-1010. Raven Press, New York.
27. Sparks D. L. and Buckholtz N. S. (1985) Combined inhibition of serotonin uptake and oxidative deamination attenuates audiogenic seizures in DBA/2J mice. Pharmacology Biochemistry and Behaviour 23: 753-757.
28. Wada Y., Hasegawa H., Nakamura M. and Yamaguchi N. (1992) Behavioral and electroencephalographic effects of aserotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy. Neuro-science Letters 138: 115-118.
29. Wada Y., Shiraishi J., Nakamura M. and Hasegawa H. (1995) Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology (Berlin) 118: 305-309.
30. Yan Q.-S., Jobe P. C. and Dailey J. W. (1994a) Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. European Journal of Pharmacology 252: 105-122.
31. Yan Q.-S., Jobe P. C., Cheong J. H., Ko K. H. and Dailey J. W. (1994b) Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn-Schmiedeberg's Archives of Pharmacology 350: 149-251.
32. Yan Q.-S., Jobe P. C. and Dailey J. W. (1995) Further evidence of anticonvulsant role for 5-hyroxytryptamine in genetically epilepsy-prone rats. British Journal of Pharmacology 115: 1314-1318.
33. Zifa E. and Fillion G. (1992) 5-Hydroxytryptamine receptors. Pharmacological Review 44: 401-457.